Aznar, AL, Canton, R, Loren, G, Carvajal, J, de la Calle, I, Masferrer-Ferragutcasas, C, Serra, F, Bebia, V, Bonaldo, G, Angeles, MA, Cabrera, S, Palomar, N, Vilarmau, C, Marti, M, Rigau, M, Colas, E, Gil-Moreno, A. Current challenges and emerging tools in endometrial cancer diagnosis. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2025; 35(4)DOI:10.1016/j.ijgc.2024.100056. PMID:40011116. IF:4.700(Q1/1D).

Gallego, A, Madariaga, A, Estévez-García, P, Alberti, F, Carbó, A, Palacio, I, Churruca, C, Gálvez, F, Ortega, ME, Murata, P, Manzano, A, Masvidal, M, Martín-Lorente, C, Hernando, B, Lozano, I, Cueva, JF, García-Illescas, D, Gost, E, Mendiola, M, Redondo, A. An ambispective, real-world multi-center study of DOstarlimab in patients with Recurrent or Advanced DNA mismatch repair deficient/microsatellite instability-high endometrial cancer (GEICO 120-R/DORA study). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2025; 35(7)DOI:10.1016/j.ijgc.2025.101903. PMID:40382973. IF:4.700(Q1/1D).

Giorgi, M, Schettini, G, La Banca, L, Cannoni, A, Ginetti, A, Colombi, I, Habib, N, Rovira, R, Martire, F, Lazzeri, L, Zupi, E, Centini, G. Prevention and Treatment of Intraoperative Complications During Gynecological Laparoscopic Surgery: Practical Tips and Tricks-A Narrative Review. ADVANCES IN THERAPY. 2025; 42(5)DOI:10.1007/s12325-025-03165-z. PMID:40106176. IF:4.000(Q1/3D).

Centini, G, Colombi, I, Ianes, I, Perelli, F, Ginetti, A, Cannoni, A, Habib, N, Negre, RR, Martire, FG, Raimondo, D, Lazzeri, L, Zupi, E. Fertility Sparing in Endometrial Cancer: Where Are We Now?. Cancers. 2025; 17(1)DOI:10.3390/cancers17010112. PMID:39796739. IF:4.400(Q2/3D).

Rovira, R, Mereu, L, Planchamp, F, Falconer, H, El-Balat, A, Barahona, M, Fagotti, A, Querleu, D, Taskiran, C. ESGE/ESGO/SERGS consensus statement on surgical steps in minimally invasive surgery in gynecologic oncology: transperitoneal and extraperitioneal approach for paraaortic lymphadenectomy. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2024; DOI:10.1136/ijgc-2024-005796. PMID:39317443. IF:4.700(Q1/1D).

Perez-Fidalgo, JA, Gálvez-Montosa, F, Guerra, EM, Madariaga, A, Manzano, A, Martin-Lorente, C, Rubio-Pérez, MJ, Alarcón, J, Barretina-Ginesta, MP, Gaba, L. SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023). Clinical & Translational Oncology. 2024; 26(11)DOI:10.1007/s12094-024-03531-3. PMID:39008159. IF:2.500(Q3/6D).

Tapia, JC, Bosma, F, Gavira, J, Sanchez, S, Molina, MA, Sanz-Beltran, J, Martin-Lorente, C, Anguera, G, Maroto, P. Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center Retrospective Study From 2004 to 2021. Clinical Genitourinary Cancer. 2024; 22(3)DOI:10.1016/j.clgc.2024.01.019. PMID:38430859. IF:2.700(Q2/3D).

Edwards, MC, Caruana, P, Fernández, R, Martin-Lorente, C, Teixeira, N, Muñoz, R, Llurba, E, Corchero, JL, Céspedes, MV. Validating organotypic tumour slice culture as a 3D drug evaluation platform for high-grade gynaecological cancers. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).